Back to Research

Organization profile

Mybacs

Mybacs is a Swiss microbiome health company providing personalized pro-, pre-, and postbiotic nutritional supplements. It focuses on goal-oriented digestive health, skin rejuvenation, and metabolic balance through scientifically-backed formulations and diagnostic personalization tools.

Zug, SwitzerlandFounded 2018

Overview

1. Executive Summary (Confidence: High)

Mybacs® has established itself as a leading force in the European microbiome health market, bridging the gap between nutritional supplements and precision medicine.[20] Founded in 2018, the company offers a suite of personalized "biotics" (pro-, pre-, and postbiotics) designed to address specific health goals ranging from metabolic balance to dermatological health.[20] A key differentiator for mybacs is its commitment to scientific rigor, utilizing advanced metabolic modeling (MCMMs) and "digital twin" simulations to predict the success of probiotic interventions with high accuracy.[22] With a loyal customer base of over 250,000 and a 90% subscription retention rate, mybacs is effectively scaling its direct-to-consumer (D2C) model across Switzerland, Germany, and Spain.[20] The 2026 outlook emphasizes further clinical validation and the integration of cutting-edge AI to refine personalized health routines.[22]

This is an extract of the full organization profile. To access the full company profile, .

Desktop only

Research is currently available on desktop only.

The Research module is designed for larger screens. Please reopen it on a desktop or laptop to use the screener, filters, detail pages, and admin tools.